Moderna This Year: Outperforming Vaccine Stocks So Far
Moderna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
Overview of annual performance metrics for index funds highlights consistency and risk-adjusted returns to inform choices.
21,807 articlesModerna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
Cerebras stock is climbing as fresh news and growing AI demand spark investor excitement. This guide breaks down the ...
Sunrun’s stock tumbled on a day of mixed signals: strong quarterly revenue but cautious guidance for 2026. This artic...
In 2025, a surprising shift reshaped the starter-home landscape: flippers supplied more starter homes than traditiona...
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
When the world's biggest ethereum treasury buys the dip, it grabs headlines—and raises questions for everyday investo...
A new Goldman Sachs note argues that AI’s next growth wave hinges on optical networking, not just faster GPUs. Lument...
A solid move by a seasoned fund—Alpine Capital Research increases its Arrow Electronics position. Learn what this cou...
IonQ delivers a standout Q1 and a fresh price-target outlook that signals potential triple-digit gains over the next ...
A focused look at a large institutional bet on Indivior, the logic behind the $143 million investment, and how such m...
A high-profile tribute spotlights the ongoing income from music credits and the importance of estate planning for art...
Ethereum outperformed XRP in July as new institutional money flowed back into ETH. Traders debate which crypto offers...